Get startedLog in
    Picture of Protara Therapeutics logo

    TARA — Protara Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Protara Announces Positive Results From The Ongoing Phase 2 Advanced-2 Trial Of TARA-002 In Patients With NMIBC

    Picture of Protara Therapeutics logoProtara Therapeutics
    05/12/2024 12:05
    Dec 5 (Reuters) - Protara Therapeutics  TARA.O :
    * PROTARA ANNOUNCES POSITIVE RESULTS FROM THE ONGOING PHASE
2
ADVANCED-2 TRIAL OF TARA-002 IN PATIENTS WITH NMIBC
    * PROTARA THERAPEUTICS INC: IN TARA-002, FAVORABLE SAFETY &
TOLERABILITY PROFILE WITH NO GRADE 2 OR GREATER
TREATMENT-RELATED ADVERSE EVENTS

Source text:  ID:nGNX4VpKyR 
Further company coverage:  TARA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Protara Therapeutics

    See all news